2014
DOI: 10.1055/s-0034-1383141
|View full text |Cite
|
Sign up to set email alerts
|

Deutscher Konsensus 2013 zur immungenetischen Spenderauswahl für die allogene Stammzelltransplantation

Abstract: Zusammenfassung Der vorliegende 4. deutsche Konsensus zur immungenetischen Spenderauswahl f?r die allogene Stammzelltransplantation wurde von der Deutschen Gesellschaft f?r Immungenetik (DGI) und der Deutschen Arbeitsgemeinschaft f?r Knochenmark- und Blutstammzelltransplantation (DAG-KBT) gemeinsam erarbeitet und verabschiedet. Er stellt den gemeinsamen Nenner von mehr als 60?Transplantationseinheiten und fast 20 immungenetischen Sucheinheiten dar, die mehr als 3000 deutsche Patienten j?hrlich betreuen. W?hren… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…Only six depend on variations outside all exons and are rarely considered. However, the identification of null alleles defined in non‐ARD exons is handled inconsistently because of the lack of an efficient general typing strategy . Therefore, the AFs of those null alleles are most likely underestimated.…”
Section: Discussionmentioning
confidence: 99%
“…Only six depend on variations outside all exons and are rarely considered. However, the identification of null alleles defined in non‐ARD exons is handled inconsistently because of the lack of an efficient general typing strategy . Therefore, the AFs of those null alleles are most likely underestimated.…”
Section: Discussionmentioning
confidence: 99%
“…Historically, the HMAs were developed independently within each donor registry as a part of a highly specialized individual IT infrastructure . Subsequently, HMAs have been developed further to encompass the evolution of the serological and molecular HLA nomenclature and also because of the growing scientific understanding of the clinical matching requirements . In particular, the HLA typing resolution required, the number of HLA loci to be considered and the number of donors typed incompletely or at insufficient resolution have promoted a heterogeneous range of matching philosophies.…”
Section: Introductionmentioning
confidence: 99%